InsiderTrades.com logo

ALNY Insider Trading

Insider Ownership Percentage: 0.86%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $47,781,293.29

Alnylam Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Alnylam Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Alnylam Pharmaceuticals Share Price & Price History

Current Price: $251.65
Price Change: ▲ Price Increase of +7.33 (3.00%)
As of 09/22/2026 04:00 PM ET

This chart shows the closing price history over time for ALNY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Alnylam Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/1/2026David E. I. PyottDirectorSell3,830$299.18$1,145,859.401,582View SEC Filing Icon  
4/6/2026Melissa McLaughlinInsiderSell2,286$330.42$755,340.129,443View SEC Filing Icon  
4/2/2026Melissa McLaughlinInsiderSell1,624$319.59$519,014.1611,729View SEC Filing Icon  
3/3/2026Kevin Joseph FitzgeraldEVPSell1,652$319.73$528,193.9621,860View SEC Filing Icon  
3/3/2026Pushkal GargEVPSell1,775$319.74$567,538.5023,406View SEC Filing Icon  
3/2/2026Jeffrey V. PoultonEVPSell2,206$327.65$722,795.9064,273View SEC Filing Icon  
3/2/2026Kevin Joseph FitzgeraldEVPSell1,598$327.65$523,584.7023,512View SEC Filing Icon  
3/2/2026Pushkal GargEVPSell1,717$327.66$562,592.2225,181View SEC Filing Icon  
3/2/2026Tolga TangulerEVPSell1,598$327.65$523,584.7036,606View SEC Filing Icon  
3/2/2026Yvonne GreenstreetCEOSell6,799$327.65$2,227,692.3598,628View SEC Filing Icon  
2/17/2026Kevin Joseph FitzgeraldEVPSell2,041$331.96$677,530.3621,264View SEC Filing Icon  
2/13/2026Jeffrey V. PoultonEVPSell2,242$310.08$695,199.3659,802View SEC Filing Icon  
2/13/2026Kevin Joseph FitzgeraldEVPSell1,959$310.08$607,446.7223,305View SEC Filing Icon  
2/13/2026Pushkal GargEVPSell2,242$310.08$695,199.3624,848View SEC Filing Icon  
2/13/2026Tolga TangulerEVPSell1,959$310.08$607,446.7231,769View SEC Filing Icon  
2/13/2026Yvonne GreenstreetCEOSell6,958$310.08$2,157,536.6485,662View SEC Filing Icon  
1/13/2026Kevin Joseph FitzgeraldEVPSell2,290$370.33$848,055.7021,264View SEC Filing Icon  
1/12/2026Jeffrey V. PoultonEVPSell2,780$362.87$1,008,778.6057,465View SEC Filing Icon  
1/12/2026Kevin Joseph FitzgeraldEVPSell1,510$362.87$547,933.7023,554View SEC Filing Icon  
1/12/2026Pushkal GargEVPSell1,510$362.87$547,933.7022,511View SEC Filing Icon  
1/12/2026Tolga TangulerEVPSell1,510$362.87$547,933.7029,728View SEC Filing Icon  
1/12/2026Yvonne GreenstreetCEOSell9,577$362.86$3,475,110.2278,411View SEC Filing Icon  
11/17/2025Kevin Joseph FitzgeraldEVPSell12,128$452.18$5,484,039.0421,264View SEC Filing Icon  
11/13/2025Yvonne GreenstreetCEOSell10,000$451.27$4,512,700.0065,409View SEC Filing Icon  
11/12/2025Yvonne GreenstreetCEOSell15,650$453.69$7,100,248.5065,409View SEC Filing Icon  
10/3/2025Pushkal GargEVPSell3,022$451.48$1,364,372.5620,221View SEC Filing Icon  
10/2/2025Jeffrey V. PoultonEVPSell3,821$452.05$1,727,283.0554,052View SEC Filing Icon  
10/2/2025Kevin Joseph FitzgeraldEVPSell2,441$452.05$1,103,454.0525,231View SEC Filing Icon  
10/2/2025Pushkal GargEVPSell2,937$452.05$1,327,670.8523,243View SEC Filing Icon  
10/2/2025Tolga TangulerEVPSell1,405$452.05$635,130.2527,438View SEC Filing Icon  
10/2/2025Yvonne GreenstreetCEOSell8,924$452.05$4,034,094.2065,409View SEC Filing Icon  
9/9/2025Colleen F. ReitanDirectorSell18,000$467.60$8,416,800.00775View SEC Filing Icon  
8/19/2025Pushkal GargEVPSell1,455$458.41$666,986.5520,221View SEC Filing Icon  
8/18/2025Jeffrey V. PoultonEVPSell2,274$453.27$1,030,735.9850,121View SEC Filing Icon  
8/18/2025Kevin Joseph FitzgeraldEVPSell1,396$453.27$632,764.9222,719View SEC Filing Icon  
8/18/2025Michael W. BonneyDirectorSell11,250$450.00$5,062,500.0016,804View SEC Filing Icon  
8/18/2025Pushkal GargEVPSell1,396$453.27$632,764.9221,676View SEC Filing Icon  
8/18/2025Tolga TangulerEVPSell1,396$453.27$632,764.9229,466View SEC Filing Icon  
8/18/2025Yvonne GreenstreetCEOSell6,979$453.27$3,163,371.3356,221View SEC Filing Icon  
8/14/2025Dennis A. AusielloDirectorSell31,448$436.58$13,729,567.84911View SEC Filing Icon  
6/2/2025Yvonne GreenstreetCEOSell19,297$306.00$5,904,882.0048,948View SEC Filing Icon  
5/30/2025Yvonne GreenstreetCEOSell31,640$304.39$9,630,899.6048,948View SEC Filing Icon  
2/18/2025Kevin Joseph FitzgeraldEVPSell1,440$251.56$362,246.4012,881View SEC Filing Icon  
2/18/2025Pushkal GargCMOSell1,548$251.67$389,585.1611,989View SEC Filing Icon  
2/14/2025Jeffrey V. PoultonCFOSell967$255.17$246,749.3932,786View SEC Filing Icon  
2/14/2025Kevin Joseph FitzgeraldEVPSell663$255.21$169,204.2314,321View SEC Filing Icon  
2/14/2025Pushkal GargCMOSell1,561$255.17$398,320.3713,537View SEC Filing Icon  
2/14/2025Yvonne GreenstreetCEOSell1,213$255.17$309,521.2181,526View SEC Filing Icon  
1/27/2025Pushkal GargCMOSell52,592$285.00$14,988,720.0011,989View SEC Filing Icon  
1/23/2025Phillip A. SharpDirectorSell11,250$275.00$3,093,750.00View SEC Filing Icon  
12/12/2024Pushkal GargCMOSell1,752$251.00$439,752.0015,705View SEC Filing Icon  
11/26/2024Pushkal GargCMOSell1,682$250.98$422,148.3617,457View SEC Filing Icon  
11/26/2024Tolga TangulerEVPSell1,469$250.98$368,689.6213,191View SEC Filing Icon  
11/26/2024Yvonne GreenstreetCEOSell5,219$250.98$1,309,864.6278,880View SEC Filing Icon  
8/20/2024Yvonne GreenstreetCEOSell15,000$280.00$4,200,000.0073,441View SEC Filing Icon  
8/6/2024Dennis A. AusielloDirectorSell20,250$262.00$5,305,500.00136View SEC Filing Icon  
8/1/2024Yvonne GreenstreetCEOSell15,148$270.00$4,089,960.0073,441View SEC Filing Icon  
7/11/2024Yvonne GreenstreetCEOSell7,093$261.00$1,851,273.0073,441View SEC Filing Icon  
6/25/2024Jeffrey V. PoultonCFOSell1,605$231.00$370,755.0028,892View SEC Filing Icon  
6/25/2024Kevin Joseph FitzgeraldEVPSell1,198$230.99$276,726.0214,181View SEC Filing Icon  
6/25/2024Pushkal GargCMOSell2,103$230.99$485,771.9715,609View SEC Filing Icon  
6/25/2024Yvonne GreenstreetCEOSell8,301$230.99$1,917,447.9980,534View SEC Filing Icon  
6/24/2024David E. I. PyottDirectorSell32,450$220.69$7,161,390.50136View SEC Filing Icon  
5/29/2024Amy W. SchulmanDirectorSell21,700$148.60$3,224,620.008,436View SEC Filing Icon  
12/27/2023Michael W. BonneyDirectorSell30,000$195.00$5,850,000.0016,029View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Alnylam Pharmaceuticals (NASDAQ:ALNY)

92.97% of Alnylam Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALNY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Alnylam Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/22/2026Andra AP fonden56,017$16.86M0.2%-35.4%0.042%Search for SEC Filing on Google Icon
9/15/2026Anchor Investment Management LLC3,389$1.02M0.1%+20.2%0.003%Search for SEC Filing on Google Icon
9/9/2026Sequoia Financial Advisors LLC4,347$1.31M0.0%-4.7%0.003%Search for SEC Filing on Google Icon
9/9/2026Tidal Investments LLC33,541$10.10M0.0%-42.1%0.025%Search for SEC Filing on Google Icon
9/9/2026National Pension Service198,295$59.69M0.0%+7.9%0.148%Search for SEC Filing on Google Icon
9/9/2026WINTON GROUP Ltd7,880$2.37M0.1%N/A0.006%Search for SEC Filing on Google Icon
9/9/2026Engineers Gate Manager LP33,469$10.08M0.1%+3.0%0.025%Search for SEC Filing on Google Icon
9/9/2026Integrated Wealth Concepts LLC4,467$1.35M0.0%-16.9%0.003%Search for SEC Filing on Google Icon
9/9/2026NewEdge Advisors LLC2,570$0.77M0.0%+11.0%0.002%Search for SEC Filing on Google Icon
9/9/2026Beacon Investment Advisory Services Inc.99$30K0.0%-52.9%0.000%Search for SEC Filing on Google Icon
9/8/2026Allworth Financial LP1,099$0.33M0.0%-14.3%0.001%Search for SEC Filing on Google Icon
9/8/2026Arizona State Retirement System38,025$11.45M0.1%+5.9%0.028%Search for SEC Filing on Google Icon
9/8/2026West Family Investments Inc.767$0.23M0.1%N/A0.001%Search for SEC Filing on Google Icon
9/8/2026Waverly Advisors LLC823$0.25M0.0%-9.3%0.001%Search for SEC Filing on Google Icon
9/8/2026Nykredit A S43,641$13.14M0.0%N/A0.033%Search for SEC Filing on Google Icon
8/27/2026Corient Private Wealth LP23,969$7.22M0.0%-6.8%0.018%Search for SEC Filing on Google Icon
8/26/2026HighTower Advisors LLC105,045$31.62M0.0%-0.8%0.079%Search for SEC Filing on Google Icon
8/25/2026VIRGINIA RETIREMENT SYSTEMS ET Al3,980$1.20M0.0%N/A0.003%Search for SEC Filing on Google Icon
8/23/2026Wedmont Private Capital1,413$0.42M0.0%+15.6%0.001%Search for SEC Filing on Google Icon
8/23/2026HB Wealth Management LLC1,824$0.55M0.0%-8.6%0.001%Search for SEC Filing on Google Icon
8/23/2026Saudi Central Bank9,284$2.80M0.0%+90.4%0.007%Search for SEC Filing on Google Icon
8/22/2026AlphaGrep UK Ltd1,623$0.49M0.1%N/A0.001%Search for SEC Filing on Google Icon
8/22/2026Raiffeisen Bank International AG13,510$3.97M0.0%+29.7%0.010%Search for SEC Filing on Google Icon
8/22/2026denkapparat Operations GmbH2,594$0.78M0.3%+151.4%0.002%Search for SEC Filing on Google Icon
8/22/2026TD Waterhouse Canada Inc.1,825$0.55M0.0%-7.4%0.001%Search for SEC Filing on Google Icon
8/22/2026Concurrent Investment Advisors LLC7,521$2.26M0.0%+695.9%0.006%Search for SEC Filing on Google Icon
8/22/2026NEOS Investment Management LLC78,274$23.56M0.1%+13.6%0.058%Search for SEC Filing on Google Icon
8/21/2026Orion Capital Management LLC2,155$0.65M0.2%-24.5%0.002%Search for SEC Filing on Google Icon
8/21/2026Nykredit A S51,208$15.42M0.0%N/A0.038%Search for SEC Filing on Google Icon
8/21/2026B. Metzler seel. Sohn & Co. AG10,591$3.19M0.0%+25.0%0.008%Search for SEC Filing on Google Icon
8/20/2026Proficio Capital Partners LLC919$0.28M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/20/2026Quantitative Investment Management LLC7,981$2.40M0.3%+106.9%0.006%Search for SEC Filing on Google Icon
8/20/2026Two Sigma Securities LLC5,585$1.68M0.1%N/A0.004%Search for SEC Filing on Google Icon
8/20/2026Benjamin Edwards Inc.1,168$0.35M0.0%+7.6%0.001%Search for SEC Filing on Google Icon
8/20/2026GTS Securities LLC1,452$0.44M0.0%+38.0%0.001%Search for SEC Filing on Google Icon
8/20/2026Northwestern Mutual Wealth Management Co.1,151$0.35M0.0%+25.7%0.001%Search for SEC Filing on Google Icon
8/19/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC727,848$219.10M0.0%+7.4%0.544%Search for SEC Filing on Google Icon
8/19/2026Royal London Asset Management Ltd.213,589$64.30M0.1%-0.7%0.160%Search for SEC Filing on Google Icon
8/19/2026Van ECK Associates Corp58,666$17.66M0.0%+8.4%0.044%Search for SEC Filing on Google Icon
8/19/2026Nissay Asset Management Corp Japan39,482$11.89M0.1%+7.0%0.030%Search for SEC Filing on Google Icon
8/19/2026Wellington Management Group LLP2,110,407$635.30M0.1%+9.0%1.577%Search for SEC Filing on Google Icon
8/18/2026Beacon Pointe Advisors LLC1,144$0.34M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/18/2026Livforsakringsbolaget Skandia Omsesidigt1,000$0.30M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/18/2026Rakuten Investment Management Inc.17,961$5.27M0.0%N/A0.013%Search for SEC Filing on Google Icon
8/18/2026Orion Capital Management LLC2,155$0.65M0.2%N/A0.002%Search for SEC Filing on Google Icon
8/18/2026North Star Asset Management Inc.1,105$0.33M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/18/2026Empowered Funds LLC4,355$1.31M0.0%N/A0.003%Search for SEC Filing on Google Icon
8/18/2026United Capital Financial Advisors LLC4,155$1.25M0.0%N/A0.003%Search for SEC Filing on Google Icon
8/18/2026Coastal Bridge Advisors LLC941$0.28M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/18/2026Jefferies Financial Group Inc.22,095$6.65M0.0%N/A0.017%Search for SEC Filing on Google Icon
8/18/2026Public Employees Retirement System of Ohio37,998$11.44M0.0%N/A0.028%Search for SEC Filing on Google Icon
8/18/2026MASTERINVEST Kapitalanlage GmbH1,251$0.38M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/17/2026Capstone Investment Advisors LLC1,899$0.57M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/17/2026Proficio Capital Partners LLC919$0.28M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/17/2026Transamerica Financial Advisors LLC8,288$2.50M0.2%N/A0.006%Search for SEC Filing on Google Icon
8/17/2026Corient Private Wealth LP23,797$7.16M0.0%N/A0.018%Search for SEC Filing on Google Icon
8/15/2026Strategic Global Advisors LLC4,823$1.45M0.2%N/A0.004%Search for SEC Filing on Google Icon
8/15/2026Caisse de depot et placement du Quebec85,748$25.81M0.0%N/A0.064%Search for SEC Filing on Google Icon
8/15/2026Man Group plc170,907$51.45M0.1%N/A0.128%Search for SEC Filing on Google Icon
8/15/2026Jupiter Topco LLC135,545$40.81M0.0%N/A0.101%Search for SEC Filing on Google Icon
8/14/2026Canada Pension Plan Investment Board334,246$100.62M0.1%N/A0.250%Search for SEC Filing on Google Icon
8/14/2026Parkman Healthcare Partners LLC50,672$15.25M1.6%N/A0.038%Search for SEC Filing on Google Icon
8/14/2026Legal & General Group Plc924,561$278.32M0.1%N/A0.691%Search for SEC Filing on Google Icon
8/14/2026Brandywine Managers LLC2,318$0.70M0.3%N/A0.002%Search for SEC Filing on Google Icon
8/14/2026L2 Asset Management LLC768$0.23M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/13/2026Cibc World Market Inc.7,221$2.17M0.0%N/A0.005%Search for SEC Filing on Google Icon
8/13/2026OMERS ADMINISTRATION Corp4,517$1.36M0.0%N/A0.003%Search for SEC Filing on Google Icon
8/13/2026Osmosis Investment Management UK Ltd3,638$1.10M0.1%N/A0.003%Search for SEC Filing on Google Icon
8/13/2026Sanctuary Advisors LLC3,139$0.95M0.0%N/A0.002%Search for SEC Filing on Google Icon
8/13/2026Polymer Capital Management HK LTD64,957$19.55M1.0%N/A0.049%Search for SEC Filing on Google Icon
8/13/2026Connor Clark & Lunn Investment Management Ltd.666$0.20M0.0%N/A0.000%Search for SEC Filing on Google Icon
8/13/2026Meiji Yasuda Asset Management Co Ltd.1,085$0.33M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/13/2026Bank of Nova Scotia8,130$2.45M0.0%N/A0.006%Search for SEC Filing on Google Icon
8/12/2026Elevation Point Wealth Partners LLC1,316$0.40M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/12/2026Daiichi Life Insurance Co. Ltd.5,873$1.77M0.0%N/A0.004%Search for SEC Filing on Google Icon
8/12/2026Commerce Bank9,461$2.85M0.0%N/A0.007%Search for SEC Filing on Google Icon
8/12/2026Northwestern Mutual Wealth Management Co.1,151$0.35M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/12/2026Evolve Private Wealth LLC882$0.27M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/12/2026Westpac Banking Corp2,632$0.79M0.0%N/A0.002%Search for SEC Filing on Google Icon
8/12/2026Sumitomo Life Insurance Co.3,111$0.94M0.0%N/A0.002%Search for SEC Filing on Google Icon
8/12/2026Korea Investment CORP247,660$74.55M0.1%N/A0.185%Search for SEC Filing on Google Icon
8/12/2026EP Wealth Advisors LLC791$0.24M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/12/2026Ieq Capital LLC15,410$4.64M0.0%N/A0.012%Search for SEC Filing on Google Icon
8/12/2026Callan Family Office LLC3,078$0.93M0.0%N/A0.002%Search for SEC Filing on Google Icon
8/11/2026Keating Financial Advisory Services Inc.139$42K0.0%N/A0.000%Search for SEC Filing on Google Icon
8/11/2026Allworth Financial LP1,099$0.33M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/11/2026B. Metzler seel. Sohn & Co. AG10,591$3.19M0.0%N/A0.008%Search for SEC Filing on Google Icon
8/11/2026Silvant Capital Management LLC18,126$5.46M0.2%N/A0.014%Search for SEC Filing on Google Icon
8/11/2026Vise Technologies Inc.1,242$0.37M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/11/2026E Fund Management Co. Ltd.6,073$1.83M0.0%N/A0.005%Search for SEC Filing on Google Icon
8/11/2026Asahi Life Asset Management CO. LTD.1,388$0.42M0.2%N/A0.001%Search for SEC Filing on Google Icon
8/10/2026Shepherd Financial Partners LLC2,741$0.83M0.1%N/A0.002%Search for SEC Filing on Google Icon
8/10/2026West Family Investments Inc.767$0.23M0.1%N/A0.001%Search for SEC Filing on Google Icon
8/10/2026NewEdge Wealth LLC9,094$2.74M0.0%N/A0.007%Search for SEC Filing on Google Icon
8/10/2026Danske Bank A S64,555$19.43M0.0%N/A0.048%Search for SEC Filing on Google Icon
8/8/2026Wealthfront Advisers LLC9,554$2.88M0.0%N/A0.007%Search for SEC Filing on Google Icon
8/8/2026Meeder Advisory Services Inc.1,611$0.49M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/8/2026Meeder Asset Management Inc.1,570$0.47M0.0%N/A0.001%Search for SEC Filing on Google Icon
8/7/2026Citizens Financial Group Inc. RI3,682$1.11M0.0%N/A0.003%Search for SEC Filing on Google Icon
8/7/2026Grandfield & Dodd LLC3,204$0.96M0.1%N/A0.002%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Read More on Alnylam Pharmaceuticals

Today's Range

Now: $251.65
Low: $244.13
High: $255.51

50 Day Range

MA: $245.82
Low: $205.48
High: $288.41

52 Week Range

Now: $251.65
Low: $197.81
High: $495.55

Volume

1,131,784 shs

Average Volume

1,550,963 shs

Market Capitalization

$33.67 billion

P/E Ratio

46.78

Dividend Yield

N/A

Beta

0.31

Who are the company insiders with the largest holdings of Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals' top insider investors include:
  1. Phillip A Sharp (Director)
  2. Philip A Sharp (Director)
  3. John Maraganore (CEO)
  4. Barry E Greene (President)
  5. Philip A Sharp (Director)
  6. Yvonne Greenstreet (CEO)
  7. Jeffrey V Poulton (EVP)
  8. Akshay Vaishnaw (Insider)
  9. Akshay Vaishnaw (EVP)
  10. Akshay Vaishnaw (SVP)
Learn More about top insider investors at Alnylam Pharmaceuticals.

Who are the major institutional investors of Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals' top institutional shareholders include:
  1. Wellington Management Group LLP — 1.58%
  2. Legal & General Group Plc — 0.69%
  3. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.54%
  4. Bank of New York Mellon Corp — 0.37%
  5. Canada Pension Plan Investment Board — 0.25%
  6. Korea Investment CORP — 0.19%
Learn More about top institutional investors of Alnylam Pharmaceuticals stock.

Which major investors are selling Alnylam Pharmaceuticals stock?

In the last quarter, ALNY stock was sold by these institutional investors:
  1. Handelsbanken Fonder AB
  2. Tidal Investments LLC
  3. PensionDanmark Pensionsforsikringsaktieselskab
  4. Corient Private Wealth LP
  5. Royal London Asset Management Ltd.
  6. Integrated Wealth Concepts LLC
  7. HighTower Advisors LLC
  8. Orion Capital Management LLC
During the last year, company insiders that have sold Alnylam Pharmaceuticals company stock include:
  1. Yvonne Greenstreet (CEO)
  2. Jeffrey V Poulton (EVP)
  3. Tolga Tanguler (EVP)
  4. Kevin Joseph Fitzgerald (EVP)
  5. Pushkal Garg (EVP)
  6. Melissa Mclaughlin (Insider)
  7. David E I Pyott (Director)
Learn More investors selling Alnylam Pharmaceuticals stock.

Which major investors are buying Alnylam Pharmaceuticals stock?

In the previous quarter, ALNY stock was acquired by institutional investors including:
  1. Legal & General Group Plc
  2. Bank of New York Mellon Corp
  3. Canada Pension Plan Investment Board
  4. Korea Investment CORP
  5. Wellington Management Group LLP
  6. Man Group plc
  7. Mitsubishi UFJ Asset Management Co. Ltd.
  8. Jupiter Topco LLC

Alnylam Pharmaceuticals Active Insiders

Jeffrey W Dunn
CEO
John Maraganore
John Maraganore (Age 63)
CEO
Yvonne Greenstreet
Yvonne Greenstreet (Age 63)
COO
Jeffrey V Poulton
Jeffrey V Poulton (Age 58)
CFO
Phillip A Sharp
Phillip A Sharp
Director
Steven M Paul
Steven M Paul
Director
Michael W Bonney
Director
Amy W Schulman
Amy W Schulman
Director
David E I Pyott
Director
1 recent trades
Dennis A Ausiello
Dennis A Ausiello
Director
Colleen F Reitan
Colleen F Reitan
Director
Melissa Mclaughlin
Melissa Mclaughlin
Chief Human Resources Officer
2 recent trades
Laurie Keating
Laurie Keating (Age 72)
EVP
Tolga Tanguler
Tolga Tanguler
EVP
Indrani Lall Franchini
Indrani Lall Franchini (Age 54)
EVP
Kevin Joseph Fitzgerald
Kevin Joseph Fitzgerald
EVP
Akshay Vaishnaw
Akshay Vaishnaw (Age 63)
Insider
Pushkal Garg
Pushkal Garg (Age 58)
CMO